CliffBio
small molecule

EPRONTIA

TOPIRAMATE

Loss of exclusivityAugust 2040latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameEPRONTIA
Active ingredientTOPIRAMATE
Strength25MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2021
Marketing statusRX

Listed patents

PatentExpiresType
11433046August 2040use U-3415
12290503August 2040product
11911362August 2040product
11826343August 2040product
11633374August 2040product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

EPRONTIA patent cliff — loss of exclusivity August 2040 | CliffBio